Search Results - "Mehta, Vikrant"

Current Landscape of Anti-HER2 Targeted Therapy in Breast Cancer: Challenges and Future Perspectives.

Authors: Bharali, Pooja Mehta, Vikrant Chand, Subhash et al.

Source: Cancer Investigation. May2026, p1-24. 24p. 1 Illustration.

Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD⁺).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology. Feb2022, Vol. 106 Issue 4, p1435-1446. 12p.

Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD+).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology; Feb2022, Vol. 106 Issue 4, p1435-1446, 12p

Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD⁺).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology. Feb2022, Vol. 106 Issue 4, p1435-1446. 12p.

Mechanisms of Anti-Tumor Activity of Withania somnifera (Ashwagandha).

Authors: Mehta, Vikrant Chander, Harish Munshi, Anjana

Source: Nutrition & Cancer. 2021, Vol. 73 Issue 6, p914-926. 13p. 1 Diagram, 3 Charts.

Design, Synthesis and Biological Evaluation of New 5‐(2‐Nitrophenyl)‐1‐aryl‐1H‐pyrazoles as Topoisomerase Inhibitors.

Authors: Kaur, Manpreet Mehta, Vikrant Arora, Sahil et al.

Source: ChemistrySelect. 7/13/2021, Vol. 6 Issue 26, p6644-6651. 8p.

Biomedical applications of L-alanine produced by Pediococcus acidilactici BD16 (alaD⁺).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology. Feb2022, Vol. 106 Issue 4, p1435-1446. 12p.

Subjects: Pediococcus acidilactici, Streptococcus pneumoniae, Vibrio cholerae, Kidney stones, Streptococcus mutans, Klebsiella pneumoniae, Hygiene products, Cell culture

Wild-type p53 suppresses formin-binding protein-17 (FBP17) to reduce invasion.

Authors: Suman, Prabhat Mehta, Vikrant Craig, Andrew W B et al.

Source: Carcinogenesis. May2022, Vol. 43 Issue 5, p494-503. 10p.

Preparation, development and characterization of Leucaena leucocephala galactomannan (LLG) conjugated sinapic acid: A potential colon targeted prodrug.

Authors: Kaur, Jasleen Mehta, Vikrant Kaur, Gurpreet

Source: International Journal of Biological Macromolecules. May2021, Vol. 178, p29-40. 12p.

Correction to: Biomedical applications of L‑alanine produced by Pediococcus acidilactici BD16 (alaD⁺).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology. Apr2022, Vol. 106 Issue 7, p2811-2811. 1p.

Correction to: Biomedical applications of L‑alanine produced by Pediococcus acidilactici BD16 (alaD+).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology; Apr2022, Vol. 106 Issue 7, p2811-2811, 1p

Correction to: Biomedical applications of L‑alanine produced by Pediococcus acidilactici BD16 (alaD⁺).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology. Apr2022, Vol. 106 Issue 7, p2811-2811. 1p.

Correction to: Biomedical applications of L‑alanine produced by Pediococcus acidilactici BD16 (alaD⁺).

Authors: Sharma, Anshula Mehta, Vikrant Rani, Suman et al.

Source: Applied Microbiology & Biotechnology. Apr2022, Vol. 106 Issue 7, p2811-2811. 1p.

Subjects: Pediococcus acidilactici

A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the "industrial" perspective.

Authors: Mehta, Vikrant Dwivedi, Ashish Ranjan Ludhiadch, Abhilash et al.

Source: European Journal of Medicinal Chemistry. Jan2024, Vol. 263, pN.PAG-N.PAG. 1p.

Synthesis of 1,4-dihydropyrazolo[4,3-b]indoles via intramolecular C(sp2)-N bond formation involving nitrene insertion, DFT study and their anticancer assessment.

Authors: Kaur, Manpreet Mehta, Vikrant Abdullah Wani, Aabid et al.

Source: Bioorganic Chemistry. Sep2021, Vol. 114, pN.PAG-N.PAG. 1p.

Database analysis reveals endophilin A expression as a marker of metastasis and prognosis in breast cancer.

Authors: Mehta V Islam S Kasana H et al.

Source: Discover oncology [Discov Oncol] 2025 Oct 08; Vol. 16 (1), pp. 1832. Date of Electronic Publication: 2025 Oct 08.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

High levels of unfolded protein response component CHAC1 associates with cancer progression signatures in malignant breast cancer tissues.

Authors: Mehta V Suman P Chander H

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Dec; Vol. 24 (12), pp. 2351-2365. Date of Electronic Publication: 2022 Aug 05.

Publication Type: Journal Article

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Prognostic significance of CHAC1 expression in breast cancer.

Authors: Mehta V Meena J Kasana H et al.

Source: Molecular biology reports [Mol Biol Rep] 2022 Sep; Vol. 49 (9), pp. 8517-8526. Date of Electronic Publication: 2022 Jun 21.

Publication Type: Journal Article

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

Cancer informatics analysis indicates high CHAC2 associated with unfavorable prognosis in breast cancer.

Authors: Chand S Mehta V Sharma RK et al.

Source: Frontiers in oncology [Front Oncol] 2022 Dec 09; Vol. 12, pp. 1058931. Date of Electronic Publication: 2022 Dec 09 (Print Publication: 2022).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE